Antiviral Peptides - Potential in Fighting Viral Infections

Image credit: mdpi.com

What are antiviral peptides?

The peptides possessing potential to inhibit the virus are considered as antiviral peptides (AVPs). Usually, the AVPs exhibit antiviral effects by inhibiting the virus directly, but their inhibition sites and the mechanism of action vary within the viral replication cycle (Rider et al. 2011 ).

Are peptide-based antiviral therapeutics suitable for human immunodeficiency virus (HIV)?

The peptide-based antiviral therapeutics have been approved for the Human immunodeficiency virus (HIV), Influenza virus and Hepatitis virus (B and C). This review enlightens the various peptide sources and the different approaches that have contributed to the search of potential antiviral peptides.

What are antiviral peptides (AVPs)?

Antiviral peptides (AVPs) are a subset of antimicrobial peptides and are a potential resource for the development of new potent therapeutics for preventing or treating viral infection.

Why do we need antiviral peptides?

The emergence of viral epidemics throughout the world is of concern due to the scarcity of available effective antiviral therapeutics. The discovery of new antiviral therapies is imperative to address this challenge, and antiviral peptides (AVPs) represent a valuable resource for the development of novel therapies to combat viral infection.

What Is Antiviral Peptides

1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233194/
2. https://pubmed.ncbi.nlm.nih.gov/32427225/
3. https://www.nature.com/articles/s41598-020-76161-8
4. https://spj.science.org/doi/10.34133/2022/9898241
5. https://link.springer.com/article/10.1007/s10989-020-10072-0
6. https://www.sciencedirect.com/science/article/pii/S0083672921000522
7. https://www.futuremedicine.com/doi/10.2217/fvl-2021-0308

Antiviral Peptides Information

1. https://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/cplu.202100351
2. https://www.mdpi.com/1999-4915/15/4/820